http://120.24.161.253:5617/index.php?action=history&feed=atom&title=%E9%A3%9F%E7%AE%A1%E7%99%8C-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-%E8%A1%80%E6%B8%85CEA 2026-04-16T08:07:55Z 本wiki的该页面的版本历史 MediaWiki 1.30.0 http://120.24.161.253:5617/index.php?title=%E9%A3%9F%E7%AE%A1%E7%99%8C-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-%E8%A1%80%E6%B8%85CEA&diff=1463692&oldid=prev 2024-07-06T14:00:00Z

<p>修改1</p> <table class="diff diff-contentalign-left" data-mw="interface"> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="1" style="background-color: white; color:black; text-align: center;">2024年7月6日 (六) 14:00的版本</td> </tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div> </td></tr></table>

Admin http://120.24.161.253:5617/index.php?title=%E9%A3%9F%E7%AE%A1%E7%99%8C-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-%E8%A1%80%E6%B8%85CEA&diff=1463693&oldid=prev 2024-07-06T11:53:44Z

<p>导入1个版本</p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">2024年7月6日 (六) 11:53的版本</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l7" >第7行：</td> <td colspan="2" class="diff-lineno">第7行：</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==来源==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==来源==</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===血清CEA、CA19-9、CA125联合黏膜端粒酶检测对上消化道肿瘤的诊断价值（中华医学会文献）===</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===血清CEA、CA19-9、CA125联合黏膜端粒酶检测对上消化道肿瘤的诊断价值（中华医学会文献）===</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>结果:胃癌,[[食管癌]]患者[[血清CEA]]、CA19-9、CA125和黏膜端粒酶含量显著高于正常对照组及慢性胃炎组(P<del class="diffchange diffchange-inline">&lt;</del>0.05),联检其敏感性和特异性明显高于单项检测(P<del class="diffchange diffchange-inline">&lt;</del>0.05).</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>结果:胃癌,[[食管癌]]患者[[血清CEA]]、CA19-9、CA125和黏膜端粒酶含量显著高于正常对照组及慢性胃炎组(P<ins class="diffchange diffchange-inline">&amp;amp;lt;</ins>0.05),联检其敏感性和特异性明显高于单项检测(P<ins class="diffchange diffchange-inline">&amp;amp;lt;</ins>0.05).</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===食管癌患者围术期监测血清CEA、CA125、CA19-9和βHCG的临床意义（中华医学会文献）===</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===食管癌患者围术期监测血清CEA、CA125、CA19-9和βHCG的临床意义（中华医学会文献）===</div></td></tr> </table>

KGadmin http://120.24.161.253:5617/index.php?title=%E9%A3%9F%E7%AE%A1%E7%99%8C-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-%E8%A1%80%E6%B8%85CEA&diff=821373&oldid=prev 2021-11-23T07:23:39Z

<p>导入1个版本</p> <table class="diff diff-contentalign-left" data-mw="interface"> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="1" style="background-color: white; color:black; text-align: center;">2021年11月23日 (二) 07:23的版本</td> </tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div> </td></tr></table>

Admin http://120.24.161.253:5617/index.php?title=%E9%A3%9F%E7%AE%A1%E7%99%8C-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-%E8%A1%80%E6%B8%85CEA&diff=821370&oldid=prev 2021-10-19T13:56:59Z

<p>修改1</p> <p><b>新页面</b></p><div>主实体：[[食管癌]]，关系：[[实验室检查]] ，尾实体：[[血清CEA]]<br /> <br /> 实体ID:''380140''<br /> ==关系介绍==<br /> 待补充<br /> <br /> ==来源==<br /> ===血清CEA、CA19-9、CA125联合黏膜端粒酶检测对上消化道肿瘤的诊断价值（中华医学会文献）===<br /> 结果:胃癌,[[食管癌]]患者[[血清CEA]]、CA19-9、CA125和黏膜端粒酶含量显著高于正常对照组及慢性胃炎组(P&lt;0.05),联检其敏感性和特异性明显高于单项检测(P&lt;0.05).<br /> <br /> ===食管癌患者围术期监测血清CEA、CA125、CA19-9和βHCG的临床意义（中华医学会文献）===<br /> [[食管癌]]患者围术期监测[[血清CEA]]、CA125、CA19-9和βHCG的临床意义<br /> <br /> ===血清CEA、SCC和CYFRA21-1在食管癌早期诊断中的应用价值（中华医学会文献）===<br /> [[血清CEA]]、SCC和CYFRA21-1在[[食管癌]]早期诊断中的应用价值<br /> <br /> ===食管癌患者手术治疗前后血清CEA,CA19-9和SS检测的临床意义（中华医学会文献）===<br /> 结论:检测[[食管癌]]患者手术治疗前后[[血清CEA]]、CA19-9和SS水平的变化对了解病情、指导临床实践均具有重要的临床价值.<br /> <br /> ===食管癌患者手术治疗前后血清CEA、SCC、VEGF检测的临床意义（中华医学会文献）===<br /> 方法:应用放免法和酶联法对36例[[食管癌]]患者进行了[[血清CEA]]、SCC和VEGF检测,并与35名正常健康人作比较.</div>

Admin